Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China

Author:

Dong JianchengORCID,Wu Huiqun,Zhou Dong,Li Kaixiang,Zhang Yuanpeng,Ji Hanzhen,Tong Zhuang,Lou Shuai,Liu Zhangsuo

Abstract

AbstractCOVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread rapidly and affected most of the world since its outbreak in Wuhan, China, which presents a major challenge to the emergency response mechanism for sudden public health events and epidemic prevention and control in all countries. In the face of the severe situation of epidemic prevention and control and the arduous task of social management, the tremendous power of science and technology in prevention and control has emerged. The new generation of information technology, represented by big data and artificial intelligence (AI) technology, has been widely used in the prevention, diagnosis, treatment and management of COVID-19 as an important basic support. Although the technology has developed, there are still challenges with respect to epidemic surveillance, accurate prevention and control, effective diagnosis and treatment, and timely judgement. The prevention and control of sudden infectious diseases usually depend on the control of infection sources, interruption of transmission channels and vaccine development. Big data and AI are effective technologies to identify the source of infection and have an irreplaceable role in distinguishing close contacts and suspicious populations. Advanced computational analysis is beneficial to accelerate the speed of vaccine research and development and to improve the quality of vaccines. AI provides support in automatically processing relevant data from medical images and clinical features, tests and examination findings; predicting disease progression and prognosis; and even recommending treatment plans and strategies. This paper reviews the application of big data and AI in the COVID-19 prevention, diagnosis, treatment and management decisions in China to explain how to apply big data and AI technology to address the common problems in the COVID-19 pandemic. Although the findings regarding the application of big data and AI technologies in sudden public health events lack validation of repeatability and universality, current studies in China have shown that the application of big data and AI is feasible in response to the COVID-19 pandemic. These studies concluded that the application of big data and AI technology can contribute to prevention, diagnosis, treatment and management decision making regarding sudden public health events in the future.

Publisher

Springer Science and Business Media LLC

Subject

Health Information Management,Health Informatics,Information Systems,Medicine (miscellaneous)

Reference130 articles.

1. WHO. Coronavirus disease (COVID-19): situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ (accessed February 25, 2021).

2. NCBI. Novel coronavirus complete genome from the Wuhan outbreak now available in GenBank. https://ncbiinsights.ncbi.nlm.nih.gov/2020/01/13/novel-coronavirus/ (accessed September 16, 2020).

3. The State Council Information Office of the People's Republic of China. Fighting COVID-19: China in action (white book). Xinhua Monthly 2020;13: 12–39 (in Chinese).

4. Zhao XM, Li XH, Nie CH. Backtracking transmission of COVID-19 in China based on big data source, and effect of strict pandemic control policy. Bull Chin Acad Sci , 2020; 35: 248-254 (in Chinese).

5. Qu SN, Yang DH. Intelligent response to sudden public health events: theoretical retrospection and trend analysis. Reform 2020; 3: 14-21 (in Chinese).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3